** Shares of Imricor Medical Systems IMR.AX rise 4.5% to A$1.525
** Stock rose as much as 7.2% to A$1.565 earlier in the day, its largest intraday pct gain since February 14
** The medical device developer narrows FY24 adjusted net loss to $15.6 million vs $16.7 million last year
** Also logs revenue $959,424 for fiscal 2024, up from $615,568 last year
** Says revenue growth driven by capital sales and new site activations
** More than 258,000 shares change hands vs 30-day avg volume of 236,000 shares
** Stock up 13.2% YTD, including current session's moves
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.